Ostrosky-Zeichner L - Search Results

1

Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit.

Faiz S, Neale B, Rios E, Campos T, Parsley E, Patel B, Ostrosky-Zeichner L. Faiz S, et al. Eur J Clin Microbiol Infect Dis. 2009 Jun;28(6):689-92. doi: 10.1007/s10096-008-0666-4. Epub 2008 Nov 15. Eur J Clin Microbiol Infect Dis. 2009. PMID: 19011913

2

In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates.

Arikan S, Ostrosky-Zeichner L, Lozano-Chiu M, Paetznick V, Gordon D, Wallace T, Rex JH. Arikan S, et al. J Clin Microbiol. 2002 Apr;40(4):1406-12. doi: 10.1128/JCM.40.4.1406-1412.2002. J Clin Microbiol. 2002. PMID: 11923365 Free PMC article.

3

Voriconazole salvage treatment of invasive candidiasis.

Ostrosky-Zeichner L, Oude Lashof AM, Kullberg BJ, Rex JH. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):651-5. doi: 10.1007/s10096-003-1014-3. Epub 2003 Oct 17. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14564539

4

New approaches to the risk of Candida in the intensive care unit.

Ostrosky-Zeichner L. Ostrosky-Zeichner L. Curr Opin Infect Dis. 2003 Dec;16(6):533-7. doi: 10.1097/00001432-200312000-00004. Curr Opin Infect Dis. 2003. PMID: 14624102 Review.

5

Novel approaches to antifungal prophylaxis.

Ostrosky-Zeichner L. Ostrosky-Zeichner L. Expert Opin Investig Drugs. 2004 Jun;13(6):665-72. doi: 10.1517/13543784.13.6.665. Expert Opin Investig Drugs. 2004. PMID: 15174952 Review.

6

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L. Odabasi Z, et al. Clin Infect Dis. 2004 Jul 15;39(2):199-205. doi: 10.1086/421944. Epub 2004 Jun 28. Clin Infect Dis. 2004. PMID: 15307029

7

Prophylaxis and treatment of invasive candidiasis in the intensive care setting.

Ostrosky-Zeichner L. Ostrosky-Zeichner L. Eur J Clin Microbiol Infect Dis. 2004 Oct;23(10):739-44. doi: 10.1007/s10096-004-1215-4. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15372315 Review.

8

Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit.

Cocanour CS, Ostrosky-Zeichner L, Peninger M, Garbade D, Tidemann T, Domonoske BD, Li T, Allen SJ, Luther KM. Cocanour CS, et al. Surg Infect (Larchmt). 2005 Spring;6(1):65-72. doi: 10.1089/sur.2005.6.65. Surg Infect (Larchmt). 2005. PMID: 15865552

9

Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials.

Paphitou NI, Ostrosky-Zeichner L, Rex JH. Paphitou NI, et al. Med Mycol. 2005 May;43(3):235-43. doi: 10.1080/13693780410001731619. Med Mycol. 2005. PMID: 16010850

10

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):654-61. doi: 10.1007/s10096-005-0024-8. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16261306 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters